Sat, Jun 27th, 2009
Related topics:
* European studies see possible cancer link
* More research needed as findings not conclusive
* Patients told to stay on treatment, consider options * Sanofi stands behind safety profile of Lantus
LONDON, June 27 (Reuters) - Sanofi-Aventis's (SASY.PA)diabetes drug Lantus may increase the risk of cancer, accordingto European studies involving some 300,000 insulin-treatedpatients, prompting a call from experts for more research.
Related stories from top sites:
Novo Nordisk's Victoza To Reach Market In A Few Weeks - CSO
Jun 19th, 2009 - Wall Street Journal
STOCKHOLM (Dow Jones)--Novo Nordisk A/S (NOVO-B.KO) expects its closely-watched diabetes treatment Victoza to reach European customers in the nearest future, Chief Scientific Officer Mads Krogsgaard Thomsen said in an interview.
Stomach staple may reduce cancer risk for women, but not for men
Jun 19th, 2009 - NY Daily News
LONDON - Women who have their stomachs stapled can cut their cancer risk by up to 40% - but men don't seem to reap the benefit, a study shows. In another twist, losing weight through other means didn't have any cancer-fighting effect...
Survival rate after liver transplant is high
Jun 19th, 2009 - Reuters
June 20 (Reuters) - Apple Inc. (AAPL.O) chief executiveSteve Jobs, who has survived a bout of pancreatic cancer, hashad a liver transplant, according to the Wall Street Journal.
Green tea 'slows prostate cancer'
Jun 19th, 2009 - BBC NEWS
Green tea has already been linked to health benefits A chemical found in green tea appears to slow the progression of prostate cancer, a study has suggested. Green tea has been linked to a positive effect on a wide range of conditions...
Related videos from YouTube:
- FDA Alert on Regranex Diabetes...According to the FDA, the drug Regranex, used to treat diabetic ulcers, may increase the risk of cancer deaths in patients using three tubes + per month by up to 500%! Brought to you by www.usrecallnews.com .
- Review of diabetes drug...David Kendall, MD from the International Diabetes Center in Minneapolis, MN discusses recent concerns on diabetes drug safety including TZDs, GLP-1 agonists and long-acting insulin analogs ...
- Possible Cancer Risk with LantusFDA is investigating the possibility that Lantus (insulin glargine) may be associated with an increased risk of cancer. Three of four observational studies published recently in the journal ...
- Insidermedicine in 60 - August 11...research published in The Archives of Internal Medicine, younger women with a family history of breast cancer may have a lower risk of the disease if they breast-feed. In a study of over 60000 women ...
Related stories from Digg:
Diabetes Drug Could Cause Pancreatic Cancer
The popular diabetes drug sitagliptin (marketed as Januvia) may increase the risk of pancreatic cancer, according to study conducted by researchers from the University of California-Los Angeles and published in the journal Diabetes.(Health)
Mikay2009Mon, Sep 28th, 20093 Diggs, 0 CommentsCoffee: The New Health Food - By Melody Hart
Want a drug that can lower your risk of diabetes, Parkinson’s disease and colon cancer? That could lift your moods and treat headaches? That could lower your risk of cavities? Harvard research studies found that downing one to three cups of America’s favorite caffeinated morning beverage can reduce diabetes risk by single digits.(Food & Drink)
ChicagoHealersFri, Aug 28th, 20091 Diggs, 0 Comments5 Risks Linked to Diabetes Medications Like Lantus, Avandia,
Cancer, heart failure, fractures, and eye and liver problems among some diabetes drugs' possible risks.(General Sciences)
HumanistRuthTue, Aug 18th, 20092 Diggs, 0 Comments
Leave a Reply